Literature DB >> 16148170

Enzyme-linked immunosorbent assays for detection of equine antibodies specific to Sarcocystis neurona surface antigens.

Jessica S Hoane1, Jennifer K Morrow, William J Saville, J P Dubey, David E Granstrom, Daniel K Howe.   

Abstract

Sarcocystis neurona is the primary causative agent of equine protozoal myeloencephalitis (EPM), a common neurologic disease of horses in the Americas. We have developed a set of enzyme-linked immunosorbent assays (ELISAs) based on the four major surface antigens of S. neurona (SnSAGs) to analyze the equine antibody response to S. neurona. The SnSAG ELISAs were optimized and standardized with a sample set of 36 equine sera that had been characterized by Western blotting against total S. neurona parasite antigen, the current gold standard for S. neurona serology. The recombinant SnSAG2 (rSnSAG2) ELISA showed the highest sensitivity and specificity at 95.5% and 92.9%, respectively. In contrast, only 68.2% sensitivity and 71.4% specificity were achieved with the rSnSAG1 ELISA, indicating that this antigen may not be a reliable serological marker for analyzing antibodies against S. neurona in horses. Importantly, the ELISA antigens did not show cross-reactivity with antisera to Sarcocystis fayeri or Neospora hughesi, two other equine parasites. The accuracy and reliability exhibited by the SnSAG ELISAs suggest that these assays will be valuable tools for examining the equine immune response against S. neurona infection, which may help in understanding the pathobiology of this accidental parasite-host interaction. Moreover, with modification and further investigation, the SnSAG ELISAs have potential for use as immunodiagnostic tests to aid in the identification of horses affected by EPM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148170      PMCID: PMC1235790          DOI: 10.1128/CDLI.12.9.1050-1056.2005

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  38 in total

1.  Seroprevalence of antibodies to Sarcocystis neurona in horses residing in Ohio.

Authors:  W J Saville; S M Reed; D E Granstrom; K W Hinchcliff; C W Kohn; T E Wittum; S Stamper
Journal:  J Am Vet Med Assoc       Date:  1997-02-15       Impact factor: 1.936

2.  Seroprevalence of antibodies to Sarcocystis neurona in horses residing in a county of southeastern Pennsylvania.

Authors:  B G Bentz; D E Granstrom; S Stamper
Journal:  J Am Vet Med Assoc       Date:  1997-02-15       Impact factor: 1.936

3.  Seroprevalence of antibodies to Sarcocystis neurona in horses residing in Oregon.

Authors:  L L Blythe; D E Granstrom; D E Hansen; L L Walker; J Bartlett; S Stamper
Journal:  J Am Vet Med Assoc       Date:  1997-02-15       Impact factor: 1.936

4.  Experimental induction of equine protozoal myeloencephalitis in horses using Sarcocystis sp. sporocysts from the opossum (Didelphis virginiana).

Authors:  C K Fenger; D E Granstrom; A A Gajadhar; N M Williams; S A McCrillis; S Stamper; J L Langemeier; J P Dubey
Journal:  Vet Parasitol       Date:  1997-02       Impact factor: 2.738

5.  Improvement of western blot test specificity for detecting equine serum antibodies to Sarcocystis neurona.

Authors:  M G Rossano; L S Mansfield; J B Kaneene; A J Murphy; C M Brown; H C Schott; J C Fox
Journal:  J Vet Diagn Invest       Date:  2000-01       Impact factor: 1.279

6.  Neosporosis as a cause of equine protozoal myeloencephalitis.

Authors:  A E Marsh; B C Barr; J Madigan; J Lakritz; R Nordhausen; P A Conrad
Journal:  J Am Vet Med Assoc       Date:  1996-12-01       Impact factor: 1.936

Review 7.  Standardisation and validation of enzyme-linked immunosorbent assay techniques for the detection of antibody in infectious disease diagnosis.

Authors:  P F Wright; E Nilsson; E M Van Rooij; M Lelenta; M H Jeggo
Journal:  Rev Sci Tech       Date:  1993-06       Impact factor: 1.181

8.  Equine protozoal myeloencephalitis: antigen analysis of cultured Sarcocystis neurona merozoites.

Authors:  D E Granstrom; J P Dubey; S W Davis; R Fayer; J C Fox; K B Poonacha; R C Giles; P F Comer
Journal:  J Vet Diagn Invest       Date:  1993-01       Impact factor: 1.279

9.  Sarcocystis neurona n. sp. (Protozoa: Apicomplexa), the etiologic agent of equine protozoal myeloencephalitis.

Authors:  J P Dubey; S W Davis; C A Speer; D D Bowman; A de Lahunta; D E Granstrom; M J Topper; A N Hamir; J F Cummings; M M Suter
Journal:  J Parasitol       Date:  1991-04       Impact factor: 1.276

10.  Identification of opossums (Didelphis virginiana) as the putative definitive host of Sarcocystis neurona.

Authors:  C K Fenger; D E Granstrom; J L Langemeier; S Stamper; J M Donahue; J S Patterson; A A Gajadhar; J V Marteniuk; Z Xiaomin; J P Dubey
Journal:  J Parasitol       Date:  1995-12       Impact factor: 1.276

View more
  4 in total

Review 1.  An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).

Authors:  J P Dubey; D K Howe; M Furr; W J Saville; A E Marsh; S M Reed; M E Grigg
Journal:  Vet Parasitol       Date:  2015-02-07       Impact factor: 2.738

2.  Limited genetic diversity among Sarcocystis neurona strains infecting southern sea otters precludes distinction between marine and terrestrial isolates.

Authors:  J M Wendte; M A Miller; A K Nandra; S M Peat; P R Crosbie; P A Conrad; M E Grigg
Journal:  Vet Parasitol       Date:  2009-12-22       Impact factor: 2.738

Review 3.  Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.

Authors:  S M Reed; M Furr; D K Howe; A L Johnson; R J MacKay; J K Morrow; N Pusterla; S Witonsky
Journal:  J Vet Intern Med       Date:  2016-02-09       Impact factor: 3.333

4.  Seroepidemiology of Sarcocystis neurona and Neospora hughesi infections in domestic donkeys (Equus asinus) in Durango, Mexico.

Authors:  Cosme Alvarado-Esquivel; Daniel K Howe; Michelle R Yeargan; Domingo Alvarado-Esquivel; José Alfredo Zamarripa-Barboza; Jitender P Dubey
Journal:  Parasite       Date:  2017-07-21       Impact factor: 3.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.